MedPath

High-flow nasal oxygenation in sedated lung transplant patients during transbronchial biopsy

Not Applicable
Recruiting
Conditions
ung transplant patients
Oxygenation during transbronchial biopsy
Lung transplant patients
Anaesthesiology - Anaesthetics
Respiratory - Other respiratory disorders / diseases
Registration Number
ACTRN12619000292178
Lead Sponsor
Dr Charles Cartwright
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Aged >=18 years old
Lung transplant patients
Undergoing transbronchial biopsy
English speaking and able to provide informed consent

Exclusion Criteria

Aged <18 years old
Non-lung transplant patients
Participants not having transbronchial biopsies conducted
Non-English speaking and unable to provide informed consent
Pre-procedure: respiratory failure/cardiovascular failure/recent pneumothorax (<2 weeks)
Chest tube in-situ
Reduced level of consciousness
Pregnant women
Unable to have the procedure carried out with a propofol infusion
Significant aspiration risk (e.g. gastroparesis/severe GORD) or unable to have the procedure done without endotracheal intubation
Unsuitable for nasal cannulae – recent nasal surgery/epistaxis, significant nasal or sinus issue, marked septal deviation, basal skull fracture
Clinical need for an LMA/intubation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The proportion of participants experiencing a desaturation (defined as SpO2 <94%)[At any point during the bronchoscopy - from the point that the monitoring equipment (including pulse oximeter) and oxygen delivery device are attached in the operating theatre to the point at which they are removed. <br><br>Observations will be automatically uploaded onto the study computer at regular intervals (e.g. every 10 seconds for oxygen saturation). ]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath